Use of eculizumab in autologous hematopoietic stem cell transplantation-associated thrombotic microangiopathy in two adults-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of eculizumab in autologous hematopoietic stem cell transplantation-associated thrombotic microangiopathy in two adults

Published:2021-10-20 Issue:2 Volume:63 Page:473-477
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Alhomoud Mohammad¹,Williams Aquino²,Magro Cynthia³,Van Besien Koen¹,Vesole David H.²,Laurence Jeffrey¹

Affiliation:

1. Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA

2. Department of Medicine, John Theurer Cancer Center at Hackensack Meridian School of Medicine, Hackensack, NJ, USA

3. Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA

Funder

Omeros, Inc

Angelo Donghia Foundation

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.1992625

Reference17 articles.

1. Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies

2. MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab

3. Allogeneic reactivity–mediated endothelial cell complications after HSCT: a plea for consensual definitions

4. Efficacy and Safety of Eculizumab in the Treatment of Transplant-Associated Thrombotic Microangiopathy: A Systematic Review and Meta-Analysis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. THE UTILITY OF THE NORMAL THIN SECTION SKIN BIOPSY IN THE ASSESSMENT OF SYSTEMIC/EXTRACUTANEOUS DISEASE;Clinics in Dermatology;2024-09

2. Risk factors for transplant-associated thrombotic microangiopathy (TA-TMA): a systematic review and meta-analysis;Expert Review of Hematology;2023-01-02

3. Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches;Journal of Clinical Investigation;2022-08-01

4. Multiple drugs;Reactions Weekly;2022-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3